NRX 194204

· NuRx Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NRX 194204, covering 2009-09-03 to 2021-05-14. Get the full timeline:

Most recent: Clinical Trial Update: Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer [Phase 2]